Wrong, with several major players among mega-sized diversified investment funds expressing extreme disappointment with the process, the outcome and the issues yet to come.
The fundamental problem is that cancer is an enormously complex, unpredictable evolutionary process characterized by extreme genetic and epigenetic diversity that occurs within the patient.